School of Medicine
Showing 601-700 of 1,039 Results
-
Maya Mathur
Assistant Professor (Research) of Pediatrics, of Medicine (Biomedical Informatics) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsSynthesizing evidence across studies while accounting for biases
-
Michael V. McConnell, MD, MSEE
Clinical Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsMy imaging research has involved clinical and molecular Imaging of cardiovascular disease, with a focus on coronary and vascular diseases, including atherosclerosis, aortic aneurysms, and vascular inflammation.
My prevention research has involved innovative technologies to reduce coronary and vascular disease, including early disease detection plus leveraging mobile health and AI to enhance heart heart in patients and populations. -
Tracey McLaughlin
Professor of Medicine (Endocrinology)
Current Research and Scholarly InterestsDr. McLaughlin conducts clinical research related to obesity, insulin resistance, diabetes, and cardiovascular disease (CVD). Current studies include: 1) the impact of macronutrient composition on metabolism, DM2 and CVD; 2) comparison of different weight loss diets on metabolism and CVD risk reduction ; 3) role of adipocytes and adipose tissue immune cells in modulating insulin resistance; 4) use of continuous glucose monitoring and multi-omics to define metabolic phenotype and precision diets
-
Bruno Medeiros
Adjunct Clinical Associate Professor, Medicine - Hematology
Current Research and Scholarly InterestsMy clinical activities combine the development of novel therapeutic modalities, translational research activities and epidemiological study of acute leukemia. My special focus is on the development of better, patient tailored therapies for young and elderly patients with acute leukemia.
-
Natalia Medvedeva
Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr Natalia Medvedeva specializes in the treatment of infectious diseases. She has a special interest in antimicrobial stewardship and medical education.
-
Mark Mercola
Professor of Medicine (Cardiovascular) and, by courtesy, of Chemical and Systems Biology
BioDr. Mercola is Professor of Medicine and Professor in the Stanford Cardiovascular Institute. He completed postdoctoral training at the Dana-Farber Cancer Institute and Harvard Medical School, was on the faculty in the Department of Cell Biology at Harvard Medical School for 12 years, and later at the Sanford-Burnham-Prebys Institute and Department of Bioengineering at the University of California, San Diego before relocating to Stanford in 2015.
Prof. Mercola is known for identifying many of the factors that are responsible for inducing and forming the heart, including the discovery that Wnt inhibition is a critical step in cardiogenesis that provided the conceptual basis and reagents for the large-scale production of cardiovascular tissues from pluripotent stem cells. He has collaborated with medicinal chemists, optical engineers and software developers to pioneer the use of patient iPSC-cardiomyocytes for disease modeling, safety pharmacology and drug development. His academic research is focused on developing and using quantitative high throughput assays of patient-specific cardiomyocyte function to discover druggable targets for preserving contractile function in heart failure and promoting regeneration following ischemic injury. He co-established drug screening and assay development at the Conrad Prebys Drug Discovery Center (San Diego), which operated as one of 4 large screening centers of the US National Institutes of Health (NIH) Molecular Libraries screening initiative and continues as one of the largest academic drug screening centers.
Prof. Mercola received an NIH MERIT award for his work on heart formation. He holds numerous patents, including describing the invention of the first engineered dominant negative protein and small molecules for stem cell and cancer applications. He serves on multiple editorial and advisory boards, including Vala Sciences, Regencor, The Ted Rogers Centre for Heart Research and the Human Biomolecular Research Institute. His laboratory is funded by the National Institutes of Health (NIH), California Institute for Regenerative Medicine, Phospholamban Foundation and Fondation Leducq. -
Thomas Charles Merigan M.D.
George E. and Lucy Becker Professor of Medicine, Emeritus
Current Research and Scholarly InterestsI am now emeritus and only participate in university activities through advising my former trainees who have joined the faculty.
-
Everett Meyer
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy), of Pediatrics (Stem Cell Transplantation) and, by courtesy, of Surgery (Abdominal Transplantation)
Current Research and Scholarly InterestsResearch focus in T cell immunotherapy and T cell immune monitoring using high-throughput sequencing and genomic approaches, with an emphasis on hematopoietic stem cell transplantation, the treatment of graft-versus-host disease and immune tolerance induction.
-
Timothy Meyer
Stanford University Professor of Nephrology, Emeritus
Current Research and Scholarly InterestsInadequate removal of uremic solutes contributes to widespread illness in the more than 500,000 Americans maintained on dialysis. But we know remarkably little about these solutes. Dr. Meyer's research efforts are focused on identifying which uremic solutes are toxic, how these solutes are made, and how their production could be decreased or their removal could be increased. We should be able to improve treatment if we knew more about what we are trying to remove.
-
Lekha Mikkilineni
Assistant Professor of Medicine (Blood and Marrow Transplantation & Cellular Therapy)
BioDr. Lekha Mikkilineni is a board-certified medical oncologist. She is also an Assistant Professor in the Department of Medicine, Division of Blood & Marrow Transplant and Cellular Therapy.
Dr. Mikkilineni has extensive experience treating blood and bone marrow cancers. She currently provides care through the Bone Marrow Transplant & Cellular Therapy Program at Stanford Health Care. Her clinical focus is multiple myeloma, plasma-cell leukemia, Extramedullary myeloma, high-risk myeloma, CAR T cell therapy, bispecific therapy, amyloidosis, POEMS syndrome, and Waldenstrom’s macroglobunemia.
Dr. Mikkilineni’s research centers on exploring novel CAR T-cell therapies to treat multiple myeloma and to define mechanisms of resistance to immunotherapy. She is particularly focused on understanding how to improve therapies for multiple myeloma patients who have extramedullary disease or high-risk features. Prior to coming to Stanford, she ran phase 1 CAR T-cell trials for multiple myeloma targeting BCMA and SLAMF7 at the National Cancer Institute.
Dr. Mikkilineni received the Conquer Cancer Foundation Young Investigator Award from the American Society of Clinical Oncology for her research focusing on SLAMF7 as a potential target for multiple myeloma. She has received honors and awards for her work at the NCI. She has completed fellowships in hematology/oncology and immunotherapy at the National Heart, Lung, and Blood Institute/National Cancer Institute. She finished her residency in internal medicine at Thomas Jefferson University Hospital. She holds a Master of Science in medical sciences from Boston University and a medical degree from Tulane University.
Dr. Mikkilineni has authored book chapters and published research in numerous high-impact academic journals. She has presented her findings through oral and poster presentations at national and international conferences. -
David Miklos
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsDr. Miklos is the Chief of BMT & Cell Therapy Program. He leads clinical trials treating patients with lymphoma. His correlative research studies: 1) tumor antigen quantification, 2) single cell functional product characterization, 3) CAR-FACS immune phenotyping of blood and tumor, and identifying mechanisms for CAR-T treatment Failure including antigen loss, CAR-T exhaustion, and CAR suppression.
-
Carlos Milla
Professor of Pediatrics (Pulmonary Medicine) and, by courtesy, of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsAt Stanford University I developed and currently direct the CF Translational Research Center. The overarching goal of the center is to provide the groundwork to streamline, accelerate, and promote the translation of basic discoveries into effective therapies and interventions to benefit patients affected by cystic fibrosis. My laboratory group currently has three main lines of investigation: respiratory cell biology in CF; remote biochemical monitoring; and lung physiology in young children.
-
Arnold Milstein
Professor of Medicine (General Medical Discipline)
Current Research and Scholarly InterestsDesign national demonstration of innovations in care delivery that provide more with less. Informed by research on AI-assisted clinical workflow, positive value outlier analysis and triggers of loss aversion bias among patients and clinicians.
Research on creation of a national index of health system productivity gain. -
Vijay Mirmira
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Mirmira believes that excellent communication leads to excellent care, and is dedicated to the health and well-being of his patients and their families. He is fluent in English, Hindi, Tamil and Kannada and has working knowledge of Urdu and Telugu. Apart from enjoying practicing the full scope of family medicine, Dr. Mirmira's special interests include diabetes and thyroid disorders, and pediatric illnesses. He likes to travel and read fiction in his free time.
-
Beverly S. Mitchell, M.D.
George E. Becker Professor of Medicine
Current Research and Scholarly InterestsBeverly Mitchell's research relates to the development of new therapies for hematologic malignancies, including leukemias and myelodsyplastic syndromes. She is interested in preclinical proof of principle studies on mechanisms inducing cell death and on metabolic targets involving nucleic acid biosynthesis in malignant cells. She is also interested in the translation of these studies into clinical trials.
-
Maha Abdalla Mohamed, MD, FACP, FAST
Clinical Associate Professor, Medicine - Nephrology
BioDr. Mohamed is a board-certified, fellowship-trained nephrologist with the Kidney and Pancreas Transplant Program at Stanford Healthcare. She is a clinical associate professor in the Department of Medicine, Division of Nephrology.
Dr. Mohamed specializes in kidney and pancreas transplant outcomes and kidney transplant health equity. Conditions she treats include allografts rejection, recipient BK virus and CMV infection, and post-transplant lymphoproliferative disorder management. Dr. Mohamed is known for her personalized and comprehensive approach to patient care. She takes the time to understand her patients’ unique health needs and creates tailored care plans that fit their lifestyles.
Dr. Mohamed’s research interests include examining new approaches to improving kidney transplant long-term outcome including kidney transplant rejection and infection. She also seeks to develop better screening and monitoring guidance to help reduce post-transplant BK virus and CMV infection.
Dr. Mohamed’s published work can be found in peer-reviewed journals such as Clinical Transplantation, Transplant Infectious Disease and Transplantation. She has presented to her peers at international, national, and regional meetings, including at the American Transplant Congress and the American Society of Nephrology. She has also been invited to speak multiple times at King Faisal Hospital in Rwanda as well as in Kingdom of Saudi Arabia on topics like post-transplant lymphoproliferative disorder, update in kidney transplant rejection, and update in living-donor kidney transplantation.
Dr. Mohamed is a faculty fellow of Stanford Center for Innovation in Global Health, fellow of the American Society of Transplantation, a board of managers member of the AST Transplant Nephrology Fellowship Training Accreditation Program, member of the International Society of Nephrology and the American Society of Nephrology. -
Minal Moharir
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioI was born, raised, and trained in Nashik, India where I completed my formal Medical Education before moving to New York City where I completed my residency in Internal Medicine at New York Downtown Hospital in New York, NY. My interests are in preventative medicne, health and wellness, occupational and environmental safety. In Stanford's Occupational Health Department, I practice clinical occupational medicine while working toward identifying health and safety issues within our enviroment to prevent further injury and illness to our employees.
-
Tamara Montacute, MD, MPH
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioTamara Kailoa Montacute is a board certified Family Medicine physician. She enjoys taking care of the entire family (including kids), and has special interest in women’s health, adolescent health, community health, chronic disease management, mental health and office based procedures. She also speaks Spanish.
She was born in New Zealand, grew up in England and moved to Seattle when she was twelve. Prior to attending medical school at Stanford, she completed her Masters in Public Health at Columbia University and spent several years working on public health programs in Mexico, Panama, Ethiopia and Rwanda. After medical school, she completed a Family Medicine Residency at O’Connor Hospital in San Jose. She is the co-medical director of Arbor Free Clinic, teaches several primary care focused medical student courses and spends part of her time caring for patients at the Samaritan House Free Clinics in Redwood City and San Mateo.
Outside the clinic, she enjoys hiking, biking, gardening and playing with her daughter and 2 dogs. -
Joshua Mooney
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsOutcomes and Health Services Research in Advanced Lung Disease & Lung Transplant
-
Nancy Morioka-Douglas, MD, MPH
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly Interests--Community outreach to underserved populations to address health care disparities, chronic illness prevention, and health promotion.
--Chronic illness care: implementing optimal care for these patients and training the next generation of physicians in these best practices.
--Enhancing physician and staff satisfaction in caring for patients -
Lori Muffly
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsDr. Muffly's interests include health services research and clinical trials with a focus on acute leukemia and blood and marrow transplantation.
-
Kelly P. Murphy, MD
Adjunct Clinical Associate Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsGlobal Health: rural healthcare delivery systems and grassroots health education.
Medical Development: collaborating with an international team of NGOs to rebuild the national healthcare system in Papua New Guinea. -
Mark Musen
Stanford Medicine Professor of Biomedical Informatics Research, Professor of Medicine (Biomedical Informatics) and of Biomedical Data Science
Current Research and Scholarly InterestsModern science requires that experimental data—and descriptions of the methods used to generate and analyze the data—are available online. Our laboratory studies methods for creating comprehensive, machine-actionable descriptions both of data and of experiments that can be processed by other scientists and by computers. We are also working to "clean up" legacy data and metadata to improve adherence to standards and to facilitate open science broadly.
-
Sanjiv Narayan
Professor of Medicine (Cardiovascular Medicine)
On Partial Leave from 09/05/2023 To 06/30/2024Current Research and Scholarly InterestsDr. Narayan directs the Computational Arrhythmia Research Laboratory, whose goal is to define the mechanisms underlying complex human heart rhythm disorders, to develop bioengineering-focused solutions to improve therapy that will be tested in clinical trials. The laboratory has been funded continuously since 2001 by the National Institutes of Health, AHA and ACC, and interlinks a disease-focused group of clinicians, computational physicists, bioengineers and trialists.
-
Ashwin K Nayak
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsConversational AI, Large Language Models, Digital Therapeutics
-
Joel Neal, MD, PhD
Associate Professor of Medicine (Oncology)
Current Research and Scholarly InterestsI am a thoracic oncologist who cares for patients with non-small cell lung cancer, malignant mesothelioma, and other thoracic malignancies. I design and conduct clinical trials of novel therapies in collaboration with other researchers and pharmaceutical companies. These generally focus on two areas, 1) targeted therapies against particular mutations in cancers (for example EGFR, ALK, ROS1, HER2, KRAS, MET, and others) and 2) the emerging field of immunotherapy in cancer, using anti PD-1/PD-L1 therapies in combination with other agents, and also developing cellular therapies. I also collaborate with other researchers on campus to apply emerging technologies to cancer therapy, for example, circulating tumor DNA detection. Additionally, in my role as the Cancer Center IT Medical Director, I coordinate projects relating to our use of the electronic health record to improve provider efficiency and facilitate patient care.
-
Robert Negrin
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsOur labaratory focuses on the study of immune recognition by T and NK cells with special emphasis on graft vs host disease and graft vs tumor reactions. We utilize both murine and human systems in an effort to enhance graft vs tumor reactions while controlling graft vs host disease. We have developed bioluminescence models in collaboration with the Contag laboratory to study the trafficking of immune effector cells with a special emphasis on NK, T and regulatory T cells.
-
Joanna Nelson
Clinical Associate Professor, Medicine - Infectious Diseases
BioDr. Nelson is a board certified Infectious Disease specialist. She specializes in the treatment of immunocompromised patients, including patients who have had solid organ or bone marrow transplantation or who have malignancy undergoing chemotherapy. She also has a special interest in caring for patients with Cystic fibrosis or who have had a lung transplant as well as Nontuberculous mycobacterial Infections.
-
Carter Neugarten
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Neugarten is a national expert at the crossroads of palliative care and emergency medicine. He has published widely in his field, and his initiatives focus on enhancing upstream palliative care accessibility, resource optimization in healthcare, and harnessing telemedicine's potential in providing care.
His contributions include co-chairing a national committee that fosters innovation by merging these fields, and he has received grant funding to study the impact of palliative care referral from the ED.
Dr. Neugarten also has an established footprint in medical education, having held multiple formal teaching roles throughout his career. -
Andrew Nevins
Clinical Professor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsClinical general infectious diseases. Medical education.
-
Kim-Son Nguyen
Adjunct Clinical Assistant Professor, Medicine - Oncology
BioDr. Kim-Son H. Nguyen obtained his Bachelor of Arts degree from Harvard College, with a concentration in genetics, his Doctor of Medicine from Harvard Medical School, and Master of Public Administration from the Harvard Kennedy School of Government before becoming a faculty member of Harvard Medical School. He then completed his fellowship in hematology and oncology at Stanford University School of Medicine and Stanford Cancer Institute. While maintaining an active clinical practice at Palo Alto Medical Foundation, Dr. Nguyen is an adjunct clinical assistant professor of medicine at Stanford University School of Medicine, with research interests including the molecular epidemiology of lung cancer, cancer screening, cancer therapeutics, and cancer care delivery.
With a unique training and extensive experience in cancer genetics, clinical research, and public policy, Dr. Nguyen has been involved in improving cancer care globally for many years. A former director of the American Society of Clinical Oncology International Program in Vietnam, he is passionate about bringing the latest oncology knowledge to cancer-treating health care providers in resource-limited settings, improving cancer care in disadvantaged patient populations, and promoting clinical research in developing countries. -
Linda Nguyen
Clinical Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsMy research interests focus on disorder of gastrointestinal motility. Specifically, those related to nausea and vomiting with or without gastroparesis, irritable bowel syndrome and chronic abdominal pain. My research focuses on understanding the cause of symptoms and development of new treatments targeting either symptom control and disease modification.
-
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Professor of Medicine (Gastroenterology and Hepatology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsWe conduct clinical trials and epidemiological, translational, and real-world studies of liver cancer, fatty liver (NASH, NAFLD), viral hepatitis B and C, liver cirrhosis, and liver transplant. We focus on risk identification for disease prevention and treatment for improvement of survival. We focus on sex, racial/ethnic, and socioeconomic disparities. We specialize in clinical trials, large international real-world consortium registry data, and large public/semi-public databases.
-
Quan Dong Nguyen, MD, MSc
Professor of Ophthalmology and, by courtesy, of Pediatrics and of Medicine (Immunology & Rheumatology)
Current Research and Scholarly InterestsWe have focused our research on the development of novel therapies and innovative assessment and diagnostic imaging technologies for retinal vascular and ocular inflammatory disorders, specifically diabetic retinopathy (DR), age-related macular degeneration (AMD) and uveitis. Building on our initial work describing the role of hypoxia and vascular endothelial growth factor (VEGF) in diabetic retinopathy (DR) and diabetic macular edema (DME), We have become interested in the biochemical mechanisms that would presumably lead to DME. During the past decade, our research has contributed to the body of evidences that defines the important role of anti-VEGF therapies in DME and AMD, as well as the role of the mTOR pathway and various interleukins in the pathogenesis of uveitis.
We have launched a productive and well-funded clinical research program while at the same time providing clinical care to patients with uveitis and retinal vascular diseases and fulfilling significant teaching and administrative assignments. We have established a number of key collaborators both within and outside the institutions. In addition, we have also established Center in Baltimore and now in Silicon Valley, which has excelled in conducting proof-of concept, early-phase multi-center clinical trials and studies, exploring the clinical disease manifestations and the efficacy of various pharmacologic agents in retinal, uveitic, and ocular inflammatory disorders. -
Mark Nicolls
Stanford University Professor of Pulmonary and Critical Care Medicine
Current Research and Scholarly InterestsOur lab focuses primarily on the contribution of the immune response to lung disease. We are specifically examining the contribution of inflammation to the development of vascular injury in transplantation, pulmonary hypertension and lymphedema.
-
Koen Nieman
Professor of Medicine (Cardiovascular Medicine) and of Radiology (CV Imaging)
Current Research and Scholarly InterestsDr Nieman investigates advanced cardiac imaging techniques. Current projects focus on the development of functional CT application for hemodynamic interpretation of coronary artery disease, and the clinical validation of cardiac CT in the management of patients with ischemic heart disease.
-
Joyce Njoroge, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Njoroge is a board-certified physician and fellowship-trained cardiologist with the Advanced Heart Failure Program at Stanford Health Care. She is also a clinical assistant professor of medicine in the Division of Cardiovascular Medicine.
Dr. Njoroge has extensive clinical experience diagnosing and treating cardiovascular complications that develop during pregnancy or postpartum. She currently provides care at the Stanford Health Care Heart and Vascular Clinic with a particular focus on patients with a history of pregnancy-associated heart failure and cardiomyopathy.
Dr. Njoroge’s research efforts involve identifying inherited genetic changes and biological markers that could help improve screening and care for pregnant women in higher risk populations. This includes determining the causes of disproportionately high incidences of heart-related complications and deaths experienced by Black women during and after pregnancy. Dr. Njoroge is also currently recruiting patients for a large-scale, multicenter clinical trial evaluating a drug to treat cardiovascular complications during pregnancy.
Dr. Njoroge has published her work in numerous prestigious peer-reviewed journals, including Circulation Research and the Journal of Cardiac Failure. She also co-authored a chapter on cardiovascular disease in pregnancy in the most recent edition of the book Current Diagnosis and Treatment: Cardiology.
Dr. Njoroge is a member of the Association of Black Cardiologists, the American College of Cardiology, the American Heart Association, and the Heart Failure Society of America. -
Dale Gene O'Brien
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDale O’Brien, MD, MPH is adjunct faculty at the Stanford University School of Medicine in the Primary Care and Population Health Division. He founded several medical clinics for vulnerable populations in under-resourced areas of northern California where he has been a practicing physician for more than four decades.
A graduate of the University of Missouri School of Medicine, he took postgraduate training at the Oregon Health & Science University, and the University of California (San Francisco) / University of California School of Public Health. He is board certified by the American Board of Family Medicine and by the American Board of Preventive Medicine.
Dr. O'Brien treated hippies at the White Bird Clinic in Eugene, Oregon in the mid-70s; served as the acting Health Officer of the Shasta County Health Department in California; and spent two years in the early 80s as an affiliate of the European Branch Headquarters of the World Health Organization in Denmark.
As the Executive Director of the nonprofit Cancer Patients Alliance (CPA) since 2001, Dr. O’Brien and his team have advocated for and supported low-income Latino community members, immigrants and farm workers with cancer in the Salinas Valley agricultural region of Monterey County, California.
Dr. O’Brien was Co-Principal Investigator of the Stanford Cancer Institute's Developmental Research Award in Translational Science, "Building an Academic-Community Partnership to Understand and Address Barriers to Cancer Care in the Salinas Valley Region of Monterey County," 2010 – 2015.
CPA has trained a number of Stanford University medical and post-doctoral students on behalf of the Valley Fellowship Program beginning in 2010 until the present.
Dr. O'Brien was a member of the Stanford / Medable team that developed the cancer aftercare app called TOGETHERCare - per NIH / NCI (SBIR 363) Phase 1 and 2 grants from 9/18/2017 until 9/30/2022.
Dr. O’Brien was on the Stanford-based research team in 2018 that piloted and studied the efficacy of the “Healthkey” behavioral health app for SAMHSA, CDC and the Council of State and Territorial Epidemiologists.
Beginning 2019, he was Co-Principal Investigator with the Stanford University group that has helped reduce cancer disparities by increasing access to the emerging DNA technologies - and facilitating cultural translation in Monterey County - pursuant to 4-year support from the California Initiative to Advance Precision Medicine.
In 2021, CPA received a 5-year grant award from the Robert Wood Johnson Foundation to further their advocacy work with the Latino community and farm workers with cancer in the Salinas Valley.
In June 2021, CPA was selected by the California GOTV medical academic consortium including the Stanford University School of Medicine as led by UCLA - to conduct the "Get Out the Vaccine to Stop Covid-19" initiative for low-income populations in Monterey County, California.
Since 2016 Dr. O'Brien has been on the Institutional Review Board of Clinica de Salud del Valle de Salinas. He is currently a member of the Stanford Cancer Institute Community Advisory Board. Dr. O’Brien is a past editor of the Berkeley Wellness Letter, Medicine on the Net and Cancer Informatics. -
Marily Oppezzo
Instructor, Medicine - Stanford Prevention Research Center
BioMarily Oppezzo is a behavioral and learning scientist. She completed her doctorate in Educational Psychology at Stanford in 2013. She also is a registered dietitian and has her master's of nutritional science. She completed her dietetic internship at the Palo Alto Veterans Hospital, and currently consults as a sports dietitian for Stanford's Runsafe program. Her research interests leverage her interdisciplinary training, with a focus on how to get people to change to improve their health and well-being. Specifically, these areas include: using social media to motivate physical activity changes in those with or at risk for heart disease; culturally tailoring nutrition and physical activity recommendations and education materials for an Alaskan native population; how walking can be used to improve people's cognitive and creative thinking; and applying learning theories to medical education topics.
-
Sabrina Orique
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioSabrina Orique, PhD, RN, AOCNS, is a hematology/oncology clinical nurse specialist at Stanford Health Care. She serves as adjunct faculty for Fresno Pacific University in the MSN FNP program. Her program of research entails patient safety with a focus on delivery of nursing care. Her published work includes missed nursing care, situation awareness, and early recognition of clinical deterioration. She has a Bachelor of Science in Nursing and a Master of Science in Nursing from California State University, Fresno. She earned her PhD in nursing from the University of Missouri, Columbia and is a 2015 Robert Wood Johnson Foundation Future of Nursing Scholar. She is a member of the National Association of Clinical Nurse Specialists, Oncology Nursing Society, and Sigma Theta Tau. She is certified as an oncology nurse and advanced oncology clinical nurse specialist by the Oncology Nursing Certification Cooperation.
-
Lars Osterberg, MD, MPH
Professor (Teaching) of Medicine (Primary Care and Population Health)
On Leave from 04/01/2024 To 07/03/2024Current Research and Scholarly InterestsBarriers to Humanism
Collaborative Faculty Development in Improving Humanism and Professionalism
Using Radiofrequency Identificaton technology to improve medication adherence
Impact of Learning Communities on Medical Education -
Linda K. Ottoboni, PhD, CNS
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsLearning more about the patient lived experiences with cardiac arrhythmias and their perceived resources believed to provide support to achieve Quality of Life.
-
Ana E. Pacheco-Navarro
Clinical Scholar, Medicine - Pulmonary, Allergy & Critical Care Medicine
Postdoctoral Scholar, Pulmonary and Critical Care MedicineBioDr. Pacheco-Navarro is a pulmonary and critical care physician with a research interest in long term outcomes after critical illness and the intersection of critical illness and autoimmunity.
-
Natalie Pageler
Clinical Professor, Peds/Clinical Informatics
Clinical Professor, Medicine - Biomedical Informatics ResearchCurrent Research and Scholarly InterestsIn my administrative role, I oversee the development and maintenance of clinical decision support tools within the electronic medical record. These clinical decision support tools are designed to enhance patient safety, efficiency, and quality of care. My research focuses on rigorously evaluating--1) how these tools affect clinician knowledge, attitudes, and behaviors; and 2) how these tools affect clinical outcomes and efficiency of health care delivery.
-
Neda Pakdaman
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Pakdaman practices Internal Medicine in Silicon Valley. She received her medical education at Yale University School of Medicine where she earned the Janet M. Glasgow Memorial Achievement Award for Women in Medicine. She completed her residency in Internal Medicine at Stanford University Hospital and was nominated for the Alwin Rambar-James Mark Award for Excellence in Patient Care.
Dr. Pakdaman has been involved in developing innovative models for patient centered practice delivery. She has extensive background in Concierge Medicine as well as Executive Medicine. In addition, prior to coming to Stanford, she helped initiate and served as medical director for the Palliative Care inpatient consult service at El Camino Hospital. During that time, she served as chair of the El Camino Hospital Ethics Committee and as an advisory member for the Genomics Medicine Institute at El Camino Hospital. Drawing from her experiences working in both executive health programs and retainer based practices, she joined Stanford in 2012 to help launch Stanford Concierge Medicine. She subsequently served as the Medical Director of Stanford Concierge Medicine and Stanford Executive Health for five years where she helped pilot aspects of Stanford Precision Health platform.
Dr. Pakdaman's clinical focus is adult primary care with health promotion and disease prevention/management.
Board Certified Internal Medicine 2003, 2013
Board Certified Hospice and Palliative Medicine 2008, 2018 -
Latha Palaniappan, MD, MS
Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Palaniappan has published over 200 peer reviewed manuscripts, abstracts, and book chapters over the last 20 years in the areas of chronic disease prevention and treatment in diverse populations. She has expertise in epidemiological research using big data, use of electronic health records for research, and clinical trials.
-
Jonathan P. Palma
Clinical Professor, Medicine - Biomedical Informatics Research
Current Research and Scholarly InterestsInterventional informatics to achieve examples of a learning healthcare system; optimization of commercial EMRs to support complex clinical workflows in newborn intensive care; clinical decision support; real-time clinical dashboards; electronic sign-out tools; IT-supported patient/family communication.
-
Minggui Pan, MD, PhD
Clinical Professor, Medicine - Oncology
BioDr. Pan is a board-certified, fellowship-trained medical oncologist with the Stanford Medicine Cancer Center and a clinical professor in the Department of Medicine, Division of Oncology.
He diagnoses and treats various oncological conditions and specializes in the treatment of bone and soft tissue sarcoma. He creates personalized and comprehensive care plans for each patient he serves.
Dr. Pan’s research focuses include understanding how genomic alterations impact the biological behavior and prognosis of sarcomas. In his work, he identifies new targets for developing innovative therapeutics for sarcoma treatment.
He has published more than fifty papers and many abstracts and presented in many cancer and immunology conferences. His papers have been published in the Journal of Clinical Oncology, JCO Precision Oncology, Clinical Cancer Research, Nature Review Clinical Oncology, JCO Oncology Practice, Journal of Hematology and Oncology, and other peer-reviewed journals. He has also presented to his peers at international, national, and regional meetings, including the annual meetings of American Society of Clinical Oncology, Chinese Society Of Clinical Oncology, Connective Tissue Oncology Society and others.
Dr. Pan is a member of American Society of Clinical Oncology, American Association of Immunologists, American Association for Advancement of Science, Society for Immunotherapy of Cancer, and Connective Tissue Oncology Society. Dr. Pan is also an adjunct investigator with Kaiser Permanente Division of Research. -
Hemali Vijay Panchal
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsQuality Improvement, Patient Safety, Medical Education
-
Alan C. Pao
Associate Professor of Medicine (Nephrology) and, by courtesy, of Urology
Current Research and Scholarly InterestsWe are broadly interested in how the kidneys control salt, water, and electrolyte homeostasis in the body. Our disease focus is on kidney stone disease. We use cultured kidney cells, transgenic mice, human plasma/urine samples, and electronic health record data to study the pathogenesis of kidney stone disease. Our therapeutic focus is on the development of small molecule compounds that can be used for kidney stone prevention.
-
Divya Parikh, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Divya Parikh is board-certified in both medical oncology and internal medicine. She obtained her medical degree from Boston University School of Medicine and completed both her residency and fellowship through Stanford University. During her fellowship, she simultaneously earned a Master of Science in health policy from Stanford University.
Dr. Parikh specializes in the care of patients with genitourinary cancers. In addition to her clinical responsibilities, she currently is a clinical assistant professor of medical oncology at Stanford School of Medicine. She mentors medical residents and fellows by sharing her insights, knowledge, and expertise.
Dr. Parikh has a strong research background. She has published in multiple academic journals and presented her findings through poster and oral presentations at various medical conferences. -
Victoria Parikh
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Parikh is a clinician scientist who cares for patients with and studies inherited (genetic) cardiovascular disease. She is the director of the Stanford Center for Inherited Cardiovascular Disease (SCICD) which is one of the largest of its kind in the country. SCICD integrates clinical and basic science with the expert care of patients with genetic cardiovascular conditions (e.g., cardiomyopathies, arrhythmias and vascular diseases). It provides cutting edge care for thousands of patients and families across the lifespan and integrates medical, surgical and genetics care. Our team includes physicians, nurses, advanced practice providers, genetic counselors, exercise physiologists and scientists.
Dr. Parikh's own clinical practice and laboratory are focused on the genetics of cardiomyopathies and their associated arrhythmogenic substrates. She completed clinical cardiology fellowship at Stanford School of Medicine and her medical residency at the University of California, San Francisco. Funded by multiple research grants from the NIH, her lab seeks to identify novel mechanisms and therapeutic technologies for genetic cardiomyopathy as well as better understand the natural histories of patients affected by these diseases. -
Walter Park
Associate Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsDr. Park's research interests are in the diagnosis and management of pancreatic cysts, acute and chronic pancreatitis. His approach incorporates methods in health services research including the use of observational datasets, cost-effectiveness studies, and the development of clinical cohorts.
-
Jane Parnes
Professor of Medicine, Emerita
Current Research and Scholarly InterestsThe lab is studying the mechanisms controlling B cell responsiveness and the balance between tolerance and autoimmunity. B cells deficient in CD72 are hyperresponsive to stimulation through the B cell receptor. We are examining the alterations in B cell signaling in these B cells and the mechanisms by which CD72 deficiency partially abrogates anergic tolerance. We hope to learn how deficiency in CD72 leads to spontaneous autoimmunity and increased susceptibility to induced autoimmune disease.
-
Julie Parsonnet
George DeForest Barnett Professor of Medicine and Professor of Epidemiology and Population Health
Current Research and Scholarly InterestsI am an infectious diseases epidemiologist who has done large field studies in both the US and developing countries. We research the long-term consequences of chronic interactions between the human host and the microbial world. My lab has done fundamental work establishing the role of H. pylori in causing disease and understanding its epidemiology. Currently, our research dissects how and when children first encounter microbes and the long term effects of these exposures on health.